Hybrid Hydrogel and PGS-PCL Microfiber Scaffold for Skin Tissue Engineering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current scaffolds for skin tissue engineering lack mechanical integrity and fail to effectively retain cells within the composite structure, limiting their ability to support tissue growth and regeneration.
Innovation Solution
Integration of electrospun poly(glycerol sebacate)-poly(ε-caprolactone) (PGS-PCL) microfiber scaffolds within a hybrid hydrogel made from methacrylated hyaluronic acid and methacrylated gelatin, providing enhanced mechanical properties and a porous structure to mimic the native skin tissue environment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If hydrogel scaffolds are used for skin tissue engineering, then cell retention and biocompatibility are improved, but mechanical integrity deteriorates
Solution Approach 1:
The patent combines hydrogel matrix with electrospun PGS-PCL microfiber reinforcement to create a composite scaffold that achieves both high cell retention (from hydrogel) and mechanical integrity (from microfibers). The microfibers are embedded within the hydrogel structure, forming a synergistic composite material that resolves the contradiction between softness/biocompatibility and structural strength.
Solution Approach 2:
The scaffold utilizes a porous structure with controlled pore size and distribution, where the hydrogel provides a porous gel matrix for cell infiltration and the electrospun microfibers create additional porous architecture. This porous design enables cell retention while the fiber network maintains mechanical integrity despite the open structure.
2Adaptability or versatility
If porous structure is increased to support tissue growth, then cell infiltration and nutrient diffusion are improved, but mechanical strength deteriorates
Solution Approach 1:
The scaffold employs a dual-porous architecture where the hydrogel matrix provides one level of porosity for cell infiltration and the electrospun microfiber network provides another level of porosity for nutrient diffusion. The controlled pore sizes in both components allow tissue growth while the interconnected fiber structure maintains mechanical strength despite the highly porous nature.
Solution Approach 2:
The composite structure combines the porous gel phase with the porous fiber phase, creating a hierarchical porous system. The microfibers act as structural spacers that maintain pore openness and prevent collapse, thereby preserving mechanical strength while enabling extensive porosity for tissue growth and nutrient transport.
3Reliability
If natural polymers are used to enhance biocompatibility, then cell interaction and degradation are improved, but mechanical properties and structural stability deteriorate
Solution Approach 1:
The patent creates a composite where natural polymer hydrogel (providing biocompatibility and cell interaction) is reinforced with synthetic PGS-PCL microfibers (providing mechanical strength). The hydrogel component ensures biocompatibility and controlled degradation, while the electrospun fiber component compensates for mechanical weaknesses, achieving a balance between biological performance and structural integrity.
Solution Approach 2:
Different regions of the scaffold have different material compositions optimized for specific functions: the hydrogel phase provides biocompatible cell interaction zones, while the electrospun microfiber regions provide mechanical reinforcement. This local differentiation allows the scaffold to simultaneously exhibit excellent biocompatibility where cells interact and sufficient strength where structural support is needed.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composite scaffold effectively retains cells, supports tissue growth, and maintains mechanical properties, promoting efficient skin tissue regeneration while allowing for homogeneous cell distribution and high cell viability.
Implementation Method 1
electrospun poly(glycerol sebacate)-poly(ε-caprolactone) (PGS-PCL) microfiber scaffolds
Implementation Method 2
hybrid hydrogel made from methacrylated hyaluronic acid and methacrylated gelatin
Implementation Method 3
methacrylated hyaluronic acid and methacrylated gelatin
Data Source
AI summary
The embodiments herein disclose a method of fabricating composite scaffolds for skin tissue regeneration. The methacrylated hyaluronic acid (HAMA) and methacrylated gelatin (GelMA) are synthesized. The poly (glycerol sebacate)-poly(ε-caprolactone) (PGS-PCL) microfibrous scaffolds are synthesized. The hydrogel is synthesized. The composite scaffold comprising hydrogel and poly (glycerol sebacate)-poly(ε-caprolactone) (PGS-PCL) microfibrous scaffolds is fabricated. A plurality of physico-chemical characteristics of the composite scaffold comprising hydrogel and poly (glycerol sebacate)-poly(ε-caprolactone) (PGS-PCL) microfibrous scaffolds are analysed. The physico-chemical characteristics comprises mechanical properties, swelling ratio and enzymatic degradation and scanning electron microscope imaging. The fibroblast cells are encapsulated within the composite scaffold comprising hydrogel and poly (glycerol sebacate)-poly(ε-caprolactone) (PGS-PCL) microfibrous scaffolds and hydrogels. The fibroblast cells are seeded on composite scaffold and PGS-PCL scaffold. The fibroblast cell viability, fibroblast cell attachment, fibroblast cell spreading, fibroblast cell proliferation and fibroblast cell metabolism are analysed in composite scaffolds, PGS-PCL scaffolds and hydrogels.